Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew G Muntean

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Hematologic Oncology|February 25, 2014
Mechanisms of mixed-lineage leukemiaAndrew G Muntean
Biochimica Et Biophysica Acta. Reviews on Cancer|December 29, 2020
Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progressionNirmalya Saha, Andrew G Muntean
Experimental Hematology|June 9, 2023
The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemiaHsiangyu Hu, Andrew G Muntean
Annual Review of Pathology|October 25, 2011
The pathogenesis of mixed-lineage leukemiaAndrew G Muntean, Jay L Hess
Cancer Cell|June 10, 2008
MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?Andrew G Muntean, Jay L Hess
Blood|April 30, 2005
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and developmentAndrew G Muntean, John D Crispino
The American Journal of Pathology|September 1, 2009
Epigenetic dysregulation in cancerAndrew G Muntean, Jay L Hess
Oncotarget|November 2, 2010
PAFc, a key player in MLL-rearranged leukemogenesisJiaying Tan, Andrew G Muntean, Jay L Hess
Blood|December 17, 2011
ECSASB2 mediates MLL degradation during hematopoietic differentiationJingya Wang, Andrew G Muntean, Jay L Hess
The Journal of Biological Chemistry|November 7, 2012
A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activityJingya Wang, Andrew G Muntean, Laura Wu, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Hematologic Oncology|February 25, 2014
Mechanisms of mixed-lineage leukemiaAndrew G Muntean
Biochimica Et Biophysica Acta. Reviews on Cancer|December 29, 2020
Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progressionNirmalya Saha, Andrew G Muntean
Experimental Hematology|June 9, 2023
The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemiaHsiangyu Hu, Andrew G Muntean
Annual Review of Pathology|October 25, 2011
The pathogenesis of mixed-lineage leukemiaAndrew G Muntean, Jay L Hess
Cancer Cell|June 10, 2008
MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?Andrew G Muntean, Jay L Hess
Blood|April 30, 2005
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and developmentAndrew G Muntean, John D Crispino
The American Journal of Pathology|September 1, 2009
Epigenetic dysregulation in cancerAndrew G Muntean, Jay L Hess
Oncotarget|November 2, 2010
PAFc, a key player in MLL-rearranged leukemogenesisJiaying Tan, Andrew G Muntean, Jay L Hess
Blood|December 17, 2011
ECSASB2 mediates MLL degradation during hematopoietic differentiationJingya Wang, Andrew G Muntean, Jay L Hess
The Journal of Biological Chemistry|November 7, 2012
A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activityJingya Wang, Andrew G Muntean, Laura Wu, et al.
Pageof 4